Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,473,000
-31,000 (-2.06%)
At close: Apr 29, 2026

Samsung Biologics Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-1,784,3521,083,316857,691798,056393,589
Upgrade
Depreciation & Amortization
-633,637599,101489,782308,264161,789
Upgrade
Loss (Gain) From Sale of Assets
-5,4542,1993,8662,5887,466
Upgrade
Asset Writedown & Restructuring Costs
-10,69762,655--725.89
Upgrade
Loss (Gain) From Sale of Investments
--759.34-597.28-5,152-72,653-269.12
Upgrade
Loss (Gain) on Equity Investments
--43,071-2,660499.42-27,260-13,853
Upgrade
Provision & Write-off of Bad Debts
--811.8-6,38021,51122,4074,857
Upgrade
Other Operating Activities
--10,197-33,004-711.89185,130135,132
Upgrade
Change in Accounts Receivable
-292,751-450,99230,127-305,336-120,660
Upgrade
Change in Inventory
--388,182-236,200-273,896-179,912-370,571
Upgrade
Change in Accounts Payable
--226,269409,295267,037134,59421,060
Upgrade
Change in Unearned Revenue
-37,15710.5827,19944,017-
Upgrade
Change in Other Net Operating Assets
-153,049232,511248,27643,151235,330
Upgrade
Operating Cash Flow
-2,247,8071,659,2551,666,229953,048454,596
Upgrade
Operating Cash Flow Growth
-35.47%-0.42%74.83%109.65%124.95%
Upgrade
Capital Expenditures
--1,391,741-1,303,573-995,071-956,840-406,254
Upgrade
Sale of Property, Plant & Equipment
-1,6371,3892,81164.0137.64
Upgrade
Cash Acquisitions
---601,956-1,071,525-1,081,821-
Upgrade
Sale (Purchase) of Intangibles
--83,333-73,952-110,254-52,386-14,898
Upgrade
Investment in Securities
--388,989734,318607,760-1,015,673-512,375
Upgrade
Other Investing Activities
--0-0-0178.52-0
Upgrade
Investing Cash Flow
--1,862,426-1,243,776-1,566,305-3,106,477-933,489
Upgrade
Short-Term Debt Issued
-40,000237,000758,500593,75050,000
Upgrade
Long-Term Debt Issued
-45,000892,65945,000211,903648,356
Upgrade
Total Debt Issued
-85,0001,129,659803,500805,653698,356
Upgrade
Short-Term Debt Repaid
--130,000-684,500-686,783-496,988-30,000
Upgrade
Long-Term Debt Repaid
--267,075-878,947-751,967-496,906-171,734
Upgrade
Total Debt Repaid
--397,075-1,563,447-1,438,750-993,894-201,734
Upgrade
Net Debt Issued (Repaid)
--312,075-433,788-635,250-188,241496,622
Upgrade
Issuance of Common Stock
----3,200,751-
Upgrade
Repurchase of Common Stock
--92,013----
Upgrade
Other Financing Activities
--216,417-200-12,430-0
Upgrade
Financing Cash Flow
--620,504-433,788-635,0503,000,080496,622
Upgrade
Foreign Exchange Rate Adjustments
--7,24741,59312,245-3,242831.1
Upgrade
Net Cash Flow
--242,37023,284-522,882843,40918,560
Upgrade
Free Cash Flow
-856,067355,682671,158-3,79248,343
Upgrade
Free Cash Flow Growth
-140.68%-47.01%---22.56%
Upgrade
Free Cash Flow Margin
-18.79%10.17%18.17%-0.13%3.08%
Upgrade
Free Cash Flow Per Share
-12775.144997.4714498.68-83.521123.38
Upgrade
Cash Interest Paid
-37,08162,08663,48633,94018,594
Upgrade
Cash Income Tax Paid
-602,362307,026319,321188,47342,369
Upgrade
Levered Free Cash Flow
-515,49366,655-446,65321,97862,860
Upgrade
Unlevered Free Cash Flow
-533,72587,982-395,65562,01972,052
Upgrade
Change in Working Capital
--131,493-45,375298,743-263,485-234,840
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.